Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

The policy has been outlined in an editorial in the New England Journal of Medicine (NEJM) by FDA Commissioner Marty Makary ...

The Trump Administration is considering limiting approval for COVID-19 boosters to seniors and others at high risk, pending more data, leaving some Granite Staters who want a vaccine wondering if they ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

In this final interview of a three-part video series, Jeffrey Casberg, M.S., vice president of clinical pharmacy at IPD ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...